药代动力学药物-药物相互作用及草药-药物相互作用
Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions.
作者信息
Choi Min-Koo, Song Im-Sook
机构信息
College of Pharmacy, Dankook University, Cheon-an 31116, Korea.
BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, Vessel-Organ Interaction Research Center (VOICE), Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu 41566, Korea.
出版信息
Pharmaceutics. 2021 Apr 23;13(5):610. doi: 10.3390/pharmaceutics13050610.
Abstract
Due to the growing use of herbal supplementation-ease of taking herbal supplements with therapeutics drugs (i [...].
摘要
由于草药补充剂的使用日益增加——易于将草药补充剂与治疗药物一起服用（i [...]. ）
相似文献
1
Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions.
Pharmaceutics. 2021 Apr 23;13(5):610. doi: 10.3390/pharmaceutics13050610.
2
Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment.
Eur J Clin Pharmacol. 2019 Sep;75(9):1237-1248. doi: 10.1007/s00228-019-02700-6. Epub 2019 Jun 1.
3
Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters.
Curr Drug Metab. 2014;15(8):791-807. doi: 10.2174/1389200216666150223152348.
4
Changing Trends Towards Herbal Supplements: An Insight into Safety and Herb-drug Interaction.
Curr Pharm Biotechnol. 2024;25(3):285-300. doi: 10.2174/1389201024666230718114606.
5
Pharmacokinetic and pharmacodynamic herb-drug interactions-part I. Herbal medicines of the central nervous system.
PeerJ. 2023 Nov 15;11:e16149. doi: 10.7717/peerj.16149. eCollection 2023.
6
Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions.
Drugs Aging. 2004;21(9):597-605. doi: 10.2165/00002512-200421090-00004.
7
Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?
Curr Drug Metab. 2019;20(2):130-137. doi: 10.2174/1389200219666180330124050.
8
Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions.
Front Pharmacol. 2014 Jul 9;5:162. doi: 10.3389/fphar.2014.00162. eCollection 2014.
9
Herbal supplements interactions with oral oestrogen-based contraceptive metabolism and transport.
Phytother Res. 2020 Jul;34(7):1519-1529. doi: 10.1002/ptr.6623. Epub 2020 Feb 3.
10
Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).
EXCLI J. 2014 Apr 2;13:347-91. eCollection 2014.
引用本文的文献
1
Pharmacological Profiling of and : Unraveling the Antibacterial and Anti-Cancer Potential of Chemically Active Metabolites.
J Cancer. 2025 Jan 1;16(1):12-33. doi: 10.7150/jca.96848. eCollection 2025.
2
Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation.
Nutrients. 2024 Feb 10;16(4):507. doi: 10.3390/nu16040507.
3
Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS.
Front Pharmacol. 2024 Feb 8;15:1334402. doi: 10.3389/fphar.2024.1334402. eCollection 2024.
4
Lipid Nanoparticles: An Effective Tool to Improve the Bioavailability of Nutraceuticals.
Int J Mol Sci. 2023 Oct 30;24(21):15764. doi: 10.3390/ijms242115764.
5
Cancer Metabolism as a Therapeutic Target and Review of Interventions.
Nutrients. 2023 Oct 1;15(19):4245. doi: 10.3390/nu15194245.
6
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment.
Cancers (Basel). 2023 Apr 1;15(7):2119. doi: 10.3390/cancers15072119.
7
A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges.
Nutrients. 2022 Nov 3;14(21):4637. doi: 10.3390/nu14214637.
8
Combining HPLC-DAD-QTOF-MS and HPLC-SPE-NMR to Monitor In Vitro Vitetrifolin D Phase I and II Metabolism.
Metabolites. 2021 Aug 9;11(8):529. doi: 10.3390/metabo11080529.
本文引用的文献
1
Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece.
Pharmaceutics. 2021 Feb 9;13(2):239. doi: 10.3390/pharmaceutics13020239.
2
Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition.
Pharmaceutics. 2021 Jan 23;13(2):148. doi: 10.3390/pharmaceutics13020148.
3
Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.
Pharmaceutics. 2021 Jan 19;13(1):124. doi: 10.3390/pharmaceutics13010124.
4
Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions.
Pharmaceutics. 2020 Dec 30;13(1):43. doi: 10.3390/pharmaceutics13010043.
5
Clinical Evaluation of Acetaminophen-Galgeuntang Interaction Based on Population Approaches.
Pharmaceutics. 2020 Dec 4;12(12):1182. doi: 10.3390/pharmaceutics12121182.
6
Differential Effects of 1α,25-Dihydroxyvitamin D on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In Vivo.
Pharmaceutics. 2020 Nov 23;12(11):1129. doi: 10.3390/pharmaceutics12111129.
7
Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
Arch Pharm Res. 2020 Dec;43(12):1335-1346. doi: 10.1007/s12272-020-01289-0. Epub 2020 Nov 22.
8
The Development and Validation of a Novel "Dual Cocktail" Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions.
Pharmaceutics. 2020 Sep 30;12(10):938. doi: 10.3390/pharmaceutics12100938.
9
Quasi-Irreversible Inhibition of CYP2D6 by Berberine.
Pharmaceutics. 2020 Sep 24;12(10):916. doi: 10.3390/pharmaceutics12100916.
10
Evaluation of the Pharmacokinetic Drug-Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers.
Pharmaceutics. 2020 Sep 12;12(9):869. doi: 10.3390/pharmaceutics12090869.
Zotero 插件